OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
The Global Health Network platform operates like an open, trusted online science park for health research and is used by thousands of researchers world-wide, especially in limited resource settings, with the focus on Global Health. Within this platform we have developed the AMR Knowledge Hub to support stronger coordination, knowledge sharing and faster progress in AMR research and practice across the Globe. It provides an open resource for a global community of practice for all researchers, healthcare and laboratory teams in all organisations working in AMR globally. The AMR Knowledge Hub is dynamic as we continuously review the global AMR knowledge and research landscape to identify gaps and needs on access to resources, guidelines and policy recommendations.
In this webinar, which is part of the TGHN Research in Focus series, we will:
1. Introduce The Global Health Network/Pfizer AMR Knowledge Hub to the global AMR community
2. Speakers will share experiences from the field on research and knowledge gaps to be addressed for an effective global AMR pandemic response
3. Global experts will discuss how the COVID-19 pandemic response experience could be used to combat the silent pandemic of AMR in LMICs
Speakers:
Dr Bruce Altevogt, Vice President and Head External Medical Engagement for the Hospital Business Unit, Pfizer
Dr Titus Divala, Commonwealth Scholar and Helse Nord RHF Fellow, London School of Hygiene and Tropical Medicine
Dr Fatema Rafiqi, Research Programme Manager for the Antimicrobial Resistance Benchmark, Access to Medicines Foundation
Dr Adam Zerda, Director of AMR Strategy and Development, BD
Dr Greg Frank, Director of Global Public Policy, Merck
Dr Jean-Louis Tissier, Vice President of Public and Government Affairs AMR, bioMérieux